Evolocumab's LDL Lowering Surpassed Inclisiran's in ORION-3

Results from a crossover subgroup of 92 patients in ORION-3 documented evolocumab's greater LDL-lowering efficacy compared with inclisiran.
MDedge News

source https://www.medscape.com/viewarticle/987120?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?